Concepedia

Yingfang He

YH

10

Publications

224

Citations

10

H-Index

2012

Active since

Affiliations

ETH Zurich(Current)

Beijing Normal University

University Hospital of Zurich

Roche (Switzerland)

Yale University

Yingfang He is an author at ETH Zurich specializing in tumor biology, medicine, and cancer research.

ORCID

Top concepts

Publications per year

2012–2024

10

Publications

10

miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma

Su Hu, Qian Jiang, Dongdong Luo et al. · Oncotarget · 2016 · 37 citations · Full text

, , +16

1-(4-[<sup>18</sup>F]Fluorobenzyl)-4-[(tetrahydrofuran-2-yl)methyl]piperazine: A Novel Suitable Radioligand with Low Lipophilicity for Imaging σ<sub>1</sub> Receptors in the Brain

Yingfang He, Fang Xie, Jiajun Ye et al. · Journal of Medicinal Chemistry · 2017 · 33 citations

Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging

Yingfang He, Matthias Schild, Uwe Grether et al. · Journal of Medicinal Chemistry · 2022 · 31 citations · Full text

Tetrahydroindazolone substituted 2-aminobenzamides as fluorescent probes: switching metal ion selectivity from zinc to cadmium by interchanging the amino and carbamoyl groups on the fluorophore

Jia Jia, Qinchao Xu, Ri-Chen Li et al. · Organic & Biomolecular Chemistry · 2012 · 30 citations

18F-Labeled indole-based analogs as highly selective radioligands for imaging sigma-2 receptors in the brain

Liang Wang, Jiajun Ye, Yingfang He et al. · Bioorganic & Medicinal Chemistry · 2017 · 20 citations

Rows per page

1–5 of 10